Total Funding
42
19
Total FundingCorporate Round raised
Growth Score
1 pts
Heat Score
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
192998
Algernon NeuroScience was formed to enhance the company's psychedelic DMT program for stroke and traumatic brain injury.
James Kinley: CFOPast Role: FGC Health, Chief Financial Officer
About the Company
Algernon NeuroScience (AGN Neuro) is a wholly owned private subsidiary of Algernon Pharmaceuticals (Algernon Pharma) that was formed to enhance the company's psychedelic DMT program for stroke and traumatic brain injury (TBI).
